Track topics on Twitter Track topics that are important to you
Medical and Diagnostic devices is a large interest of J&J, with products across all fields of medicine from Orthopedics prosthesis to diabetic insulin blood tests. In 2010, annual sales were $23.6 billion, making in the number 1 medical device company (based on annual sales)
Medications produced by J&J target the following main areas; cardiovascular and metabolic disease, immunology, infectious diseases, neuroscience and oncology; and are the result of an annual investment of $4.6bn in R&D. Some of the main medications include Reminyl, Invega, Axert and Topamax.
In addition to these areas, J&J also invests in products that are household names, such as baby care, dental hygiene, visual hygiene and health dietary components.
Source; BioPortfolio.com, JnJ.com and Fierce BioTech
Add the Johnson & Johnson News Channel to your RSS reader;
Follow the Johnson & Johnson Twitter feed;